OM
ANALYST COVERAGE9 analysts
BUY
+115.1%upside to target
L $7.00
Med $8.00consensus
H $15.00
Buy
778%
Hold
111%
Sell
111%
7 Buy (78%)1 Hold (11%)1 Sell (11%)
Full report →
PRICE
Prev Close
3.63
Open
3.67
Day Range3.57 – 3.79
3.57
3.79
52W Range3.00 – 21.98
3.00
21.98
4% of range
VOLUME & SIZE
Avg Volume
179.7K
FUNDAMENTALS
P/E Ratio
-1.4x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.43
Market-like
TECHNICAL
RSI (14)
44
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 20
DEx-Dividend
In 90 days
Aug 17
PDividend Pay
In 97 days
Aug 24
Key MetricsTTM
Market Cap$68.96M
Revenue TTM$117.59M
Net Income TTM-$74.85M
Free Cash Flow-$34.25M
Gross Margin40.6%
Operating Margin-56.9%
Net Margin-63.7%
Return on Equity-55.9%
Return on Assets-30.0%
Debt / Equity0.04
Current Ratio6.29
EPS TTM$-4.07

OM News

About

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Industry
Electromedical and Electrotherapeutic Apparatus Manufacturing
Leslie L. TriggPresident, Chief Executive Officer & Chairman
Amelia MerrillVice President of People Operations & Culture
Dinamarie StefaniSenior Vice President of Regulatory Affairs & Quality Assurance
Michael AragonChief Medical Officer
Brett FoggSenior Vice President of R&D & Operations
Derick ElliottExecutive Vice President of Commercial
James S. MazzolaVice President of Corporate Communications & Investor Relations
John L. BrottemGeneral Counsel & Secretary
Marc NashExecutive Vice President of R&D, Operations & Service
Brittni McGillChief Nursing Officer
Renee GaetaChief Financial Officer, Principal Financial Officer & Principal Accounting Officer
John GeraciVice President & Controller